Roche, CH0012032048

Accu-Chek Guide by Roche - connected glucose meter with app support

Published on 07/18/2026 at 09:01 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Accu-Chek Guide from Roche logs blood glucose readings with a spill-resistant strip port and Bluetooth sync to the mySugr app. This product is driving the price of Roche Holding AG stock (ISIN CH0012032048).

Extreme Nahaufnahme roter Blutzellen auf Glasträger, wissenschaftliche Visualisierung in Rot
Roche Holding AG CH0012032048 – Extreme Makroaufnahme roter Blutzellen auf wissenschaftlichem Glasträger, Illustration mit AI erstellt.

Accu-Chek Guide from Roche sits on the kitchen table, its rubberized edges cool under the fingers while a test strip clicks into place with a quiet snap. The backlit display glows in the dim morning light as a tiny blood drop triggers the next reading.

Connected glucose meter basics

Accu-Chek Guide is a Bluetooth-enabled blood glucose meter designed for people with diabetes who test regularly and want digital logging instead of handwritten diaries. A key detail is the spill-resistant strip port that holds strips securely, even if the box is jostled.

The device works with Accu-Chek Guide test strips and can transmit readings to compatible smartphone apps like the mySugr app and Accu-Chek Connect, depending on the market. Each reading is stored with date and time, and users can add tags such as "before meal" or "after exercise" for context.

Dig deeper & contextualize

Roche Holding AG and Accu-Chek Guide in investor focus

Understand how Roche’s diabetes care portfolio, including Accu-Chek Guide, feeds into diagnostics revenue and long-term digital health strategy.

Strip handling and everyday use

The strip vial has a textured surface that feels slightly rough against the palm, and the strips are designed so that blood is applied at the end rather than on top, supporting more consistent sampling. Roche highlights a built-in strip eject button, helping users dispose of used strips without touching them.

In practice, this means someone can test at a desk or in a car without balancing an open vial of strips on their knee. A user menu lets them set target ranges, audible reminders, and units (mg/dL or mmol/L), reflecting Roche’s focus on both European and North American markets.

Data, apps and clinician reports

The Accu-Chek Guide meter can connect via Bluetooth to Roche’s Accu-Chek Connect app or to the mySugr app, which is part of Roche’s digital diabetes ecosystem. Once paired, readings appear almost instantly on the phone screen, and trends can be visualized as graphs over days or months.

Roche’s diabetes care digital lead Marcel Gmür has repeatedly emphasized in conference presentations that combining meter data with app-based insights helps physicians see patterns such as recurrent high readings after dinner. Exported PDFs or cloud-based reports can be sent to clinics ahead of appointments, saving time during short consultations.

Portfolio position and stock angle

For Roche, Accu-Chek Guide sits in the broader Accu-Chek family alongside devices such as Accu-Chek Instant and Accu-Chek Guide Link, but focuses specifically on self-monitoring of blood glucose in ambulatory settings. The product is available in many European markets, North America, and parts of Asia, often bundled with test strip subscription offers through pharmacies and online channels.

In diagnostics reporting, Roche separates Diabetes Care within its point-of-care business, where meters like Accu-Chek Guide contribute to recurring test strip revenue and digital service margins. Roche Holding AG stock trades on SIX Swiss Exchange, with investors watching diabetes solutions including Accu-Chek Guide as part of the diagnostics growth story.

Accu-Chek Guide key facts

  • Product: Accu-Chek Guide
  • Manufacturer: Roche Holding AG
  • Category: B2B/Pro line diabetes care diagnostics
  • Market launch: Around 2016 in initial markets, with subsequent rollouts in Europe and other regions.
  • MSRP / Price: Commonly positioned around 20–40 EUR for starter kits in European retail and pharmacy channels, depending on bundle and local pricing.
  • Availability: Widely available in pharmacies, medical device distributors and online shops across Europe and other regions where Roche’s diabetes care portfolio is approved.
  • Target group: People with diabetes who require regular blood glucose monitoring, and healthcare providers supporting them.
  • Highlight / USP: Spill-resistant strip port, Bluetooth connectivity to Roche and partner apps, and data export options for clinicians.

Accu-Chek Guide on social media

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0012032048 | ROCHE | boerse | 69793325 | bgmi